296 related articles for article (PubMed ID: 29476047)
1. Correlating chemical diversity with taxonomic distance for discovery of natural products in myxobacteria.
Hoffmann T; Krug D; Bozkurt N; Duddela S; Jansen R; Garcia R; Gerth K; Steinmetz H; Müller R
Nat Commun; 2018 Feb; 9(1):803. PubMed ID: 29476047
[TBL] [Abstract][Full Text] [Related]
2. Chapter 3. Discovering natural products from myxobacteria with emphasis on rare producer strains in combination with improved analytical methods.
Garcia RO; Krug D; Müller R
Methods Enzymol; 2009; 458():59-91. PubMed ID: 19374979
[TBL] [Abstract][Full Text] [Related]
3. Pyxipyrrolones: Structure Elucidation and Biosynthesis of Cytotoxic Myxobacterial Metabolites.
Kjaerulff L; Raju R; Panter F; Scheid U; Garcia R; Herrmann J; Müller R
Angew Chem Int Ed Engl; 2017 Aug; 56(32):9614-9618. PubMed ID: 28590072
[TBL] [Abstract][Full Text] [Related]
4. Comparison of myxobacterial diversity and evaluation of isolation success in two niches: Kiritimati Island and German compost.
Mohr KI; Stechling M; Wink J; Wilharm E; Stadler M
Microbiologyopen; 2016 Apr; 5(2):268-78. PubMed ID: 26669488
[TBL] [Abstract][Full Text] [Related]
5. Moderately thermophilic Myxobacteria: novel potential for the production of natural products isolation and characterization.
Gerth K; Müller R
Environ Microbiol; 2005 Jun; 7(6):874-80. PubMed ID: 15892706
[TBL] [Abstract][Full Text] [Related]
6. Metabolic and Biosynthetic Diversity in Marine Myxobacteria.
Gemperlein K; Zaburannyi N; Garcia R; La Clair JJ; Müller R
Mar Drugs; 2018 Sep; 16(9):. PubMed ID: 30189599
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in discovery and biosynthesis of natural products from myxobacteria: an overview from 2017 to 2023.
Wang CY; Hu JQ; Wang DG; Li YZ; Wu C
Nat Prod Rep; 2024 Jun; 41(6):905-934. PubMed ID: 38390645
[TBL] [Abstract][Full Text] [Related]
8. Future Directions of Marine Myxobacterial Natural Product Discovery Inferred from Metagenomics.
Garcia R; La Clair JJ; Müller R
Mar Drugs; 2018 Aug; 16(9):. PubMed ID: 30158489
[TBL] [Abstract][Full Text] [Related]
9. Myxobacteria in high moor and fen: An astonishing diversity in a neglected extreme habitat.
Mohr KI; Zindler T; Wink J; Wilharm E; Stadler M
Microbiologyopen; 2017 Aug; 6(4):. PubMed ID: 28401707
[TBL] [Abstract][Full Text] [Related]
10. Expanding the Myxochelin Natural Product Family by Nicotinic Acid Containing Congeners.
Frank NA; Széles M; Akone SH; Rasheed S; Hüttel S; Frewert S; Hamed MM; Herrmann J; Schuler SMM; Hirsch AKH; Müller R
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443518
[TBL] [Abstract][Full Text] [Related]
11. Structure and biosynthesis of sorangipyranone - a new γ-dihydropyrone from the myxobacterial strain MSr12020.
Okoth DA; Hug JJ; Mándi A; Kurtán T; Garcia R; Müller R
J Ind Microbiol Biotechnol; 2021 Jun; 48(3-4):. PubMed ID: 34003283
[TBL] [Abstract][Full Text] [Related]
12. Marine Myxobacteria: A Few Good Halophiles.
Albataineh H; Stevens DC
Mar Drugs; 2018 Jun; 16(6):. PubMed ID: 29899205
[TBL] [Abstract][Full Text] [Related]
13. Myxobacterial natural product assembly lines: fascinating examples of curious biochemistry.
Wenzel SC; Müller R
Nat Prod Rep; 2007 Dec; 24(6):1211-24. PubMed ID: 18033576
[TBL] [Abstract][Full Text] [Related]
14. Myxobacterial natural products: An under-valued source of products for drug discovery for neurological disorders.
Dehhaghi M; Mohammadipanah F; Guillemin GJ
Neurotoxicology; 2018 May; 66():195-203. PubMed ID: 29499217
[TBL] [Abstract][Full Text] [Related]
15. Natural products from myxobacteria: novel metabolites and bioactivities.
Herrmann J; Fayad AA; Müller R
Nat Prod Rep; 2017 Feb; 34(2):135-160. PubMed ID: 27907217
[TBL] [Abstract][Full Text] [Related]
16. Global Geographic Diversity and Distribution of the Myxobacteria.
Wang J; Wang J; Wu S; Zhang Z; Li Y
Microbiol Spectr; 2021 Sep; 9(1):e0001221. PubMed ID: 34259548
[TBL] [Abstract][Full Text] [Related]
17. Expanding the Scope of Detectable Microbial Natural Products by Complementary Analytical Methods and Cultivation Systems.
Bader CD; Haack PA; Panter F; Krug D; Müller R
J Nat Prod; 2021 Feb; 84(2):268-277. PubMed ID: 33449690
[TBL] [Abstract][Full Text] [Related]
18. Constructing a Myxobacterial Natural Product Database to Facilitate NMR-Based Metabolomics Bioprospecting of Myxobacteria.
Wang DG; Wang CY; Hu JQ; Wang JJ; Liu WC; Zhang WJ; Du XR; Wang H; Zhu LL; Sui HY; Li YZ; Wu C
Anal Chem; 2023 Mar; 95(12):5256-5266. PubMed ID: 36917632
[TBL] [Abstract][Full Text] [Related]
19. In depth natural product discovery - Myxobacterial strains that provided multiple secondary metabolites.
Bader CD; Panter F; Müller R
Biotechnol Adv; 2020; 39():107480. PubMed ID: 31707075
[TBL] [Abstract][Full Text] [Related]
20. Structure, Total Synthesis, and Biosynthesis of Chloromyxamides: Myxobacterial Tetrapeptides Featuring an Uncommon 6-Chloromethyl-5-methoxypipecolic Acid Building Block.
Gorges J; Panter F; Kjaerulff L; Hoffmann T; Kazmaier U; Müller R
Angew Chem Int Ed Engl; 2018 Oct; 57(43):14270-14275. PubMed ID: 30088846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
